Quantitative Sodium MR Imaging at 7 T: Initial Results and Comparison with Diffusion-weighted Imaging in Patients with Breast Tumors.

Purpose To investigate the clinical feasibility of a quantitative sodium 23 ((23)Na) magnetic resonance (MR) imaging protocol developed for breast tumor assessment and to compare it with 7-T diffusion-weighted imaging (DWI). Materials and Methods Written informed consent in this institutional review board-approved study was obtained from eight healthy volunteers and 17 patients with 20 breast tumors (five benign, 15 malignant). To achieve the best image quality and reproducibility, the (23)Na sequence was optimized and tested on phantoms and healthy volunteers. For in vivo quantification of absolute tissue sodium concentration (TSC), an external phantom was used. Static magnetic field, or B0, and combined transmit and receive radiofrequency field, or B1, maps were acquired, and image quality, measurement reproducibility, and accuracy testing were performed. Bilateral (23)Na and DWI sequences were performed before contrast material-enhanced MR imaging in patients with breast tumors. TSC and apparent diffusion coefficient (ADC) were calculated and correlated for healthy glandular tissue and benign and malignant lesions. Results The (23)Na MR imaging protocol is feasible, with 1.5-mm in-plane resolution and 16-minute imaging time. Good image quality was achieved, with high reproducibility (mean TSC values ± standard deviation for the test, 36 mmol per kilogram of wet weight ± 2 [range, 34-37 mmol/kg]; for the retest, 37 mmol/kg ± 1 [range, 35-39 mmol/kg]; P = .610) and accuracy (r = 0.998, P < .001). TSC values in normal glandular and adipose breast tissue were 35 mmol/kg ± 3 and 18 mmol/kg ± 3, respectively. In malignant lesions (mean size, 31 mm ± 24; range, 6-92 mm), the TSC of 69 mmol/kg ± 10 was, on average, 49% higher than that in benign lesions (mean size, 14 mm ± 12; range, 6-35 mm), with a TSC of 47 mmol/kg ± 8 (P = .002). There were similar ADC differences between benign ([1.78 ± 0.23] × 10(-3) mm(2)/sec) and malignant ([1.03 ± 0.23] × 10(-3) mm(2)/sec) tumors (P = .002). ADC and TSC were inversely correlated (r = -0.881, P < .001). Conclusion Quantitative (23)Na MR imaging is clinically feasible, may provide good differentiation between malignant and benign breast lesions, and demonstrates an inverse correlation with ADC. (©) RSNA, 2016 Online supplemental material is available for this article.

[1]  Michael Bock,et al.  3D radial projection technique with ultrashort echo times for sodium MRI: Clinical applications in human brain and skeletal muscle , 2007, Magnetic resonance in medicine.

[2]  T. Helbich,et al.  Diffusion-weighted MR for differentiation of breast lesions at 3.0 T: how does selection of diffusion protocols affect diagnosis? , 2009, Radiology.

[3]  C. Clark,et al.  Sodium MR Imaging Detection of Mild Alzheimer Disease: Preliminary Study , 2009, American Journal of Neuroradiology.

[4]  David A. Bluemke,et al.  Monitoring of neoadjuvant chemotherapy using multiparametric, 23Na sodium MR, and multimodality (PET/CT/MRI) imaging in locally advanced breast cancer , 2011, Breast Cancer Research and Treatment.

[5]  T. Helbich,et al.  Three-dimensional proton MR spectroscopic imaging at 3 T for the differentiation of benign and malignant breast lesions. , 2011, Radiology.

[6]  F E Boada,et al.  Fast three dimensional sodium imaging , 1997, Magnetic resonance in medicine.

[7]  D. Bluemke,et al.  Proton, diffusion‐weighted imaging, and sodium (23Na) MRI of uterine leiomyomata after MR‐guided high‐intensity focused ultrasound: A preliminary study , 2009, Journal of magnetic resonance imaging : JMRI.

[8]  I. Cameron,et al.  Intracellular concentration of sodium and other elements as related to mitogenesis and oncogenesis in vivo. , 1980, Cancer research.

[9]  Shannon D. Gower-Winter,et al.  In vivo magnetic resonance imaging of sodium and diffusion in rat glioma at 21.1 T , 2012, Magnetic resonance in medicine.

[10]  Daniel K Sodickson,et al.  Noninvasive quantification of intracellular sodium in human brain using ultrahigh–field MRI , 2013, NMR in biomedicine.

[11]  L. Bolinger,et al.  Mapping of the Radiofrequency Field , 1993 .

[12]  Hans H Schild,et al.  Dynamic bilateral contrast-enhanced MR imaging of the breast: trade-off between spatial and temporal resolution. , 2005, Radiology.

[13]  Lagarde Ae,et al.  The Na+:H+ antiport in cancer. , 1986 .

[14]  Tamer S. Ibrahim,et al.  High‐resolution spiral imaging on a whole‐body 7T scanner with minimized image blurring , 2010, Magnetic resonance in medicine.

[15]  Peter Gibbs,et al.  Diffusion changes precede size reduction in neoadjuvant treatment of breast cancer. , 2006, Magnetic resonance imaging.

[16]  Joshua D Kaggie,et al.  A 3 T sodium and proton composite array breast coil , 2014, Magnetic resonance in medicine.

[17]  Wolfhard Semmler,et al.  Three‐dimensional biexponential weighted 23Na imaging of the human brain with higher SNR and shorter acquisition time , 2013, Magnetic resonance in medicine.

[18]  B Stoeckel,et al.  Brain tissue sodium concentration in multiple sclerosis: a sodium imaging study at 3 tesla. , 2010, Brain : a journal of neurology.

[19]  H. Leffert,et al.  Increased sodium ion influx is necessary to initiate rat hepatocyte proliferation , 1979, Cell.

[20]  M Goldsmith,et al.  NUCLEAR MAGNETIC RESONANCE AS A NEW TOOL IN CANCER RESEARCH: HUMAN TUMORS BY NMR , 1973, Annals of the New York Academy of Sciences.

[21]  Klaus Scheffler,et al.  High‐resolution quantitative sodium imaging at 9.4 tesla , 2015, Magnetic resonance in medicine.

[22]  Tiejun Zhao,et al.  High‐resolution sodium imaging of human brain at 7 T , 2012, Magnetic resonance in medicine.

[23]  Jorge Jovicich,et al.  B0 mapping with multi‐channel RF coils at high field , 2011, Magnetic resonance in medicine.

[24]  Peter Andersen,et al.  Adapted RF pulse design for SAR reduction in parallel excitation with experimental verification at 9.4 T. , 2010, Journal of magnetic resonance.

[25]  Paul A. Bottomley,et al.  Elevated tissue sodium concentration in malignant breast lesions detected with non-invasive 23Na MRI , 2007, Breast Cancer Research and Treatment.

[26]  Paul A Bottomley,et al.  Tissue sodium concentration in human brain tumors as measured with 23Na MR imaging. , 2003, Radiology.

[27]  Aiming Lu,et al.  Quantitative sodium imaging with a flexible twisted projection pulse sequence , 2010, Magnetic resonance in medicine.

[28]  T. Helbich,et al.  Bilateral diffusion-weighted MR imaging of breast tumors with submillimeter resolution using readout-segmented echo-planar imaging at 7 T. , 2015, Radiology.

[29]  T. Helbich,et al.  Multiparametric MR Imaging with High-Resolution Dynamic Contrast-enhanced and Diffusion-weighted Imaging at 7 T Improves the Assessment of Breast Tumors: A Feasibility Study. , 2015, Radiology.

[30]  Wolfgang Bogner,et al.  Dynamic Contrast-Enhanced Magnetic Resonance Imaging of Breast Tumors at 3 and 7 T: A Comparison , 2014, Investigative radiology.

[31]  Ning-Yu An,et al.  Differentiation of clinically benign and malignant breast lesions using diffusion‐weighted imaging , 2002, Journal of magnetic resonance imaging : JMRI.

[32]  Peter R Luijten,et al.  Feasibility of 7 Tesla Breast Magnetic Resonance Imaging Determination of Intrinsic Sensitivity and High-Resolution Magnetic Resonance Imaging, Diffusion-Weighted Imaging, and 1H-Magnetic Resonance Spectroscopy of Breast Cancer Patients Receiving Neoadjuvant Therapy , 2011, Investigative radiology.

[33]  S. Gruber,et al.  Clinical application of bilateral high temporal and spatial resolution dynamic contrast-enhanced magnetic resonance imaging of the breast at 7 T , 2014, European Radiology.